Deferred Tax Assets, Valuation Allowance of Cullinan Therapeutics, Inc. from 31 Dec 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Cullinan Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2019 to 31 Dec 2025.
  • Cullinan Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $173,785,000, a 33% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Cullinan Therapeutics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $173,785,000 +$42,846,000 +33% 31 Dec 2025 10-K 10 Mar 2026 2025 FY
Q4 2024 $130,939,000 +$43,568,000 +50% 31 Dec 2024 10-K 10 Mar 2026 2025 FY
Q4 2023 $87,371,000 +$40,605,000 +87% 31 Dec 2023 10-K 10 Mar 2026 2025 FY
Q4 2022 $46,766,000 +$2,214,000 +5% 31 Dec 2022 10-K 27 Feb 2025 2024 FY
Q4 2021 $44,552,000 +$21,910,000 +97% 31 Dec 2021 10-K 14 Mar 2024 2023 FY
Q3 2021 $0 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 $0 30 Jun 2021 10-Q 10 Aug 2021 2021 Q2
Q1 2021 $0 31 Mar 2021 10-Q 14 May 2021 2021 Q1
Q4 2020 $22,642,000 +$11,989,000 +113% 31 Dec 2020 10-K 09 Mar 2023 2022 FY
Q4 2019 $10,653,000 31 Dec 2019 10-K 17 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.